CONGIU, CENZO
 Distribuzione geografica
Continente #
EU - Europa 80.726
NA - Nord America 6.630
AS - Asia 1.064
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
SA - Sud America 4
Totale 88.460
Nazione #
IT - Italia 78.726
US - Stati Uniti d'America 6.585
UA - Ucraina 903
CN - Cina 774
SE - Svezia 322
FI - Finlandia 221
DE - Germania 205
GB - Regno Unito 176
SG - Singapore 143
FR - Francia 70
IN - India 44
CA - Canada 42
VN - Vietnam 32
RU - Federazione Russa 27
EG - Egitto 19
BE - Belgio 15
ES - Italia 12
NL - Olanda 12
IR - Iran 11
KR - Corea 11
HK - Hong Kong 10
TR - Turchia 7
EU - Europa 6
IE - Irlanda 6
TW - Taiwan 6
HU - Ungheria 5
AU - Australia 4
CZ - Repubblica Ceca 4
JP - Giappone 4
PL - Polonia 4
PT - Portogallo 4
RS - Serbia 4
TH - Thailandia 4
IL - Israele 3
MX - Messico 3
NG - Nigeria 3
PK - Pakistan 3
BR - Brasile 2
DK - Danimarca 2
ID - Indonesia 2
IQ - Iraq 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AR - Argentina 1
AT - Austria 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 88.460
Città #
Cagliari 78.296
Woodbridge 892
Fairfield 742
Houston 534
Chandler 533
Jacksonville 516
Wilmington 430
Ann Arbor 416
Ashburn 392
Seattle 299
Cambridge 281
Nyköping 245
Dearborn 154
Nanjing 148
Beijing 116
Boardman 116
Boston 116
Helsinki 94
Shanghai 63
Nanchang 61
Singapore 59
New York 56
Shenyang 50
Milan 48
Hebei 46
San Diego 44
Verona 40
Jiaxing 39
Redwood City 34
Dong Ket 32
Tianjin 32
Changsha 31
Guangzhou 31
Toronto 31
Mountain View 29
Auburn Hills 23
Norwalk 23
Olbia 23
Orange 21
Washington 20
Los Angeles 19
Hefei 18
Atlanta 16
Zhengzhou 16
Jinan 15
Selargius 15
Ferrara 14
Sassari 14
Falls Church 13
Hangzhou 12
Brussels 11
London 11
Ningbo 11
Rome 11
Phoenix 10
Kunming 9
Cairo 8
Chapel Hill 8
Indiana 8
Messina 8
Monserrato 8
Banha 7
Central 7
Champaign 7
Perugia 7
Tappahannock 6
Budapest 5
Fuzhou 5
Mainz 5
Quartu Sant'elena 5
Redmond 5
Taizhou 5
Altofonte 4
Bangkok 4
Barcelona 4
Belgrade 4
Columbus 4
Costa Mesa 4
Dublin 4
Gangnam-gu 4
Neoneli 4
Pune 4
San Francisco 4
San Mateo 4
Villanovafranca 4
Weihai 4
Wuhan 4
Borås 3
Brooklyn 3
Chengdu 3
Chennai 3
Florence 3
Gainesville 3
Jinhua 3
Kaohsiung City 3
Lagos 3
Maia 3
Millbury 3
Montreal 3
Nürnberg 3
Totale 85.574
Nome #
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.513
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.396
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.284
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.108
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.101
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor 2.079
Critical role for prokineticin 2 in CNS autoimmunity 2.073
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.069
Interaction of the N-(3-Methylpyridin-2-yl)amide derivatives of flurbiprofen and ibuprofen with FAAH: Enantiomeric selectivity and binding mode 2.051
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.027
Investigation of the mechanism of FAAH inhibition of profen amide derivatives 2.013
Synthesis and evaluation of new pyrazole-based carboxamides as modulators of the TrPv1 channel 1.996
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 1.958
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 1.799
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 1.795
null 1.768
null 1.650
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.615
PPAR controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development 1.555
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 1.538
An important role for prokineticin 2 in autoimmune CNS demyelination 1.509
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.445
null 1.242
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.208
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.092
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.069
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 990
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 909
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen 862
null 825
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide 791
Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents 777
null 731
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 714
null 670
null 613
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 608
Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives 560
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF DUAL FAAH – COX INHIBITORS 559
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors 557
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 515
Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines 500
Reaction of enaminonitriles with isocyanates. Synthesis of new 2-oxo- and 6-oxopyrimidines 478
null 466
null 457
Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties 453
Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues 446
Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6- trifluoromethyl-3-pyridinecarboxylic acids 442
null 424
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 416
null 416
null 414
Synthesis and antimicrobial activity of some pyrrole derivatives 400
Synthesis and antimicrobial activity of some 1-arylideneamino-2-mercaptoimidazole derivatives 395
null 378
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF NEW FAAH INHIBITORS 373
PROGETTAZIONE, SINTESI, STUDI SAR E VALUTAZIONE BIOLOGICA DI NUOVIINIBITORI DELL’ENZIMA FAAH 364
Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents 363
Synthesis and antimicrobial activity of some pyrrole derivatives. III. 2-(4-arylpiperazino)-3-ethoxycarbonyl-5-aryl-pyrrole derivatives. 362
null 361
Synthesis and structure of heterocyclic compounds, 1-amino-2,4-disubstituted imidazoles. 358
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 354
null 350
Synthesis of 6-amino and 6-ethoxy-2(1H)-pyridone derivatives. 341
null 341
null 341
Synthesis and antimicrobial activity of some pyrrole derivatives. IV. 2-arylidenhydrazino-3-ethoxycarbonyl (or cyano) pyrrole derivatives. 339
Synthesis of 1-acyl-5-pyrazolones and pyrrolidino [2,3-c]pyrazol-3-ones 337
Synthesis and antifungal activities of N-arylideneaminoimidazole derivatives. 334
null 332
DERIVATI DIARILETEROCICLICI COME POTENZIALI AGENTI ANTITUMORALI 329
null 327
Attività antimicrobica di derivati pirrolici 326
null 311
null 296
null 294
Synthesis and antimicrobial activity of some pyrrole derivatives. II: 2-(2'-acylhydrazino)-3-ethoxycarbonyl-5-aryl (or alkyl)- pyrrole derivatives 286
null 286
null 285
null 282
Synthesis of pyridines by heterocyclization of new dienamino esters. 281
Synthesis and biological activity of some pyrrole derivatives I. 279
null 278
null 276
null 273
null 270
ATTIVITA CHEMIOTERAPICA DI N-AMMINO-IMIDAZOLI ED N-ARILIDEN-AMMINO-IMIDAZOLI DI NUOVA SINTESI. NOTA PRELIMINARE. 264
null 264
null 264
Pyridazine derivatives from acyclic enamines. Chain-ring tautomeric and epimeric equilibrium in 6-hydroxy-1,4,5,6-tetrahydropyridazines. 259
Synthesis of 4-Aminopyrido[2,3-d]pyrimidines 255
null 254
null 251
On the acylation of 1,3-benzoxathiole systems. 249
null 248
null 245
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifampicina e rifabutina nei confronti di Mycobacterium avium 244
null 243
null 243
Sintesi ed attività analgesica di aza-analoghi di fenamati 242
Totale 77.173
Categoria #
all - tutte 115.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019435 0 0 0 0 0 0 0 0 0 0 0 435
2019/202019.357 1.420 767 188 708 6.360 4.112 2.428 683 513 480 461 1.237
2020/202125.043 1.013 613 1.195 6.058 5.112 3.079 2.556 1.504 513 1.106 1.192 1.102
2021/20224.171 381 345 336 236 225 315 313 293 281 470 353 623
2022/20237.310 728 724 654 517 531 903 489 1.068 465 345 575 311
2023/20249.022 422 364 444 704 971 1.619 1.555 543 443 643 732 582
Totale 88.784